Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test episode artwork

EPISODE · Nov 28, 2023 · 8 MIN

Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test

from NeuroFrontiers

Host: Andrew Wilner, MD, FACP, FAAN Guest: William A. Kilgo, MD According to new research featured at the joint ECTRIMS-ACTRIMS meeting, the Multiple Sclerosis Disease Activity (MSDA) Test is a reliable indicator of recent objective disease activity when used within an academic clinic. Based on these findings, Dr. Andrew Wilner sits down with lead author of the study, Dr. William Kilgo, to discuss how the MSDA can be applied in our real-world clinical practice.

Episode metadata supplied by the publisher feed · Published Nov 28, 2023

Embed this episode

Ready to play

Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test

0:00 8:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of NeuroFrontiers?

This episode is 8 minutes long.

When was this NeuroFrontiers episode published?

This episode was published on November 28, 2023.

Can I download this NeuroFrontiers episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!